Back to search

Japan· JP-1319710Q2019

シアノコバラミン

A cyanocobalamin product containing シアノコバラミン, registered in Japan, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

On Japan’s NHI price listATC B03BA01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedシアノコバラミンATCB03BA01REGISTER NO.JP-1319710Q2019PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Cyanocobalamin is registered in 13 of 19 countries.

Countries holding a registration under ATC B03BA01 (cyanocobalamin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 7 of them publish a price we can compare per daily dose

Cyanocobalamin · ATC B03BA01

13 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cyanocobalamin costs, country by country.

Normalised to the WHO defined daily dose (70 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cyanocobalamin · price per daily dose (70 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.031
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
シアノコバラミン
Manufacturer
—
Country
Japan (JP)
ATC code
B03BA01
ATC class
Cyanocobalamin
Defined daily dose
70 mcg, N
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

372 interactions on record for cyanocobalamin.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cyanocobalamin · interactions on record

372 records

  • 2 moderate
  • 12 minor
  • 358 info

Most severe, free to view

  • ChloramphenicolJ01BA01moderate
  • Arsenic trioxideL01XX27moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d52ca03f-456e-49cb-b223-ae61d3f7e935
GET /v1/drugs/d52ca03f-456e-49cb-b223-ae61d3f7e935?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.02%5mL1瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1319710Q2019",
  "category": "外用薬",
  "price_yen": 92.3,
  "generic_name": "シアノコバラミン",
  "product_name_jp": null,
  "therapeutic_class": "1319",
  "transitional_expiry": null
}

See everything about cyanocobalamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.